ZA733811B - Pharmaceutical compositions containing cysteine - Google Patents

Pharmaceutical compositions containing cysteine

Info

Publication number
ZA733811B
ZA733811B ZA733811A ZA733811A ZA733811B ZA 733811 B ZA733811 B ZA 733811B ZA 733811 A ZA733811 A ZA 733811A ZA 733811 A ZA733811 A ZA 733811A ZA 733811 B ZA733811 B ZA 733811B
Authority
ZA
South Africa
Prior art keywords
pharmaceutical compositions
compositions containing
containing cysteine
cysteine
pharmaceutical
Prior art date
Application number
ZA733811A
Other languages
English (en)
Inventor
G Maillard
P Muller
M Joullie
L Lakah
Original Assignee
Rech Pharm Scientifiques
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Rech Pharm Scientifiques filed Critical Rech Pharm Scientifiques
Publication of ZA733811B publication Critical patent/ZA733811B/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7004—Monosaccharides having only carbon, hydrogen and oxygen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Molecular Biology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
ZA733811A 1972-06-15 1973-06-05 Pharmaceutical compositions containing cysteine ZA733811B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR7221606A FR2187326B1 (fr) 1972-06-15 1972-06-15

Publications (1)

Publication Number Publication Date
ZA733811B true ZA733811B (en) 1974-04-24

Family

ID=9100256

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA733811A ZA733811B (en) 1972-06-15 1973-06-05 Pharmaceutical compositions containing cysteine

Country Status (7)

Country Link
US (1) US3892852A (fr)
AU (1) AU468199B2 (fr)
CA (1) CA1009150A (fr)
DE (1) DE2329821A1 (fr)
FR (1) FR2187326B1 (fr)
GB (1) GB1418208A (fr)
ZA (1) ZA733811B (fr)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES469060A1 (es) * 1978-04-22 1979-04-01 Invest Tecnica Aplicada Procedimiento para la preparacion de nuevos derivados tio- prenilicos con actividad farmacologica
FR2476484A1 (fr) * 1980-02-22 1981-08-28 Elf Aquitaine Compositions pour l'hydratation des substances keratiniques constituees par des sulfoxydes d'alpha amino acides
JPH0788352B2 (ja) * 1988-06-16 1995-09-27 エスエス製薬株式会社 ヒドロキシアルキルシステイン誘導体およびこれを含有する去痰剤
US5272166A (en) * 1990-04-09 1993-12-21 The Rockefeller University Method for selective reduction of Lp(a)
GB2245491A (en) * 1990-06-25 1992-01-08 Medvet Science Pty Ltd Inhibition of metabolic oxalate formation
GB9419061D0 (en) * 1994-09-20 1994-11-09 Holt John A G Therapeutic methods and compositions for use therein
EP0764442A1 (fr) * 1995-09-19 1997-03-26 John Alfred Gorton Holt Utilisation de dérivés specifiés d'acide aminé contenant du soufre contre particules pathogéniques virales ou prions
JP4098850B2 (ja) * 1997-07-16 2008-06-11 久光製薬株式会社 Ｓ−（３−ヒドロキシプロピル）−ｌ−システインを含有する経口用製剤
EP1080724A4 (fr) * 1998-05-22 2004-06-23 Nippon Shinyaku Co Ltd Compositions destinees a diminuer l'activite mtp
WO2001051016A1 (fr) * 2000-01-07 2001-07-19 Arthur Vanmoor Methode de traitement d'affections par amelioration de l'efficacite du systeme immunitaire humain
US6384078B1 (en) * 2000-11-21 2002-05-07 Arthur Vanmoor Method of treating elevated cholesterol levels by enhancing the effectiveness of the human immune system
JP3805646B2 (ja) * 2001-05-25 2006-08-02 久光メディカル株式会社 医薬液剤
US7226766B2 (en) * 2001-06-12 2007-06-05 University Of Iowa Research Foundation S-methylcysteine, S-ethylcysteine, and related S-alkylthiols as antagonists to the effects of S-nitrosothiols and nitric oxide
ITMI20020510A1 (it) * 2002-03-11 2003-09-11 Ghisalberti Carlo Composizioni ad uso topico contenenti derivati di l-cisteina
AU2003215522A1 (en) * 2002-03-15 2003-09-29 H. Lundbeck A/S Use of asc-1 inhibitors to treat neurological and psychiatric disorders
JP4490668B2 (ja) * 2003-10-23 2010-06-30 田辺三菱製薬株式会社 下痢治療薬
WO2008135984A1 (fr) * 2007-05-03 2008-11-13 Ramot At Tel-Aviv University Ltd. Compositions pour une régulation positive du taux de glutathiène cellulaire
CN101467991B (zh) * 2007-08-02 2012-02-01 复旦大学 烯丙基半胱氨酸及其类似物在制备治疗心肌损伤药物中的用途
KR101511056B1 (ko) 2013-06-28 2015-04-10 한밭대학교 산학협력단 신규한 ｓ-알릴 시스테인 유도체 및 그의 용도
AU2016275642C1 (en) * 2015-06-12 2020-09-17 Wakunaga Pharmaceutical Co., Ltd. Antihypertensive agent

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2888380A (en) * 1954-11-05 1959-05-26 Merck & Co Inc S-ethyl cysteine compositions for combatting tubercle bacilli
DE1025203B (de) * 1958-12-15 1958-02-27 Monsanto Chemicals Bekaempfung von Pflanzenparasiten
US3624143A (en) * 1968-05-10 1971-11-30 Merck & Co Inc Compounds of the class {62 -aralkylthio-substituted-{60 -amino acids

Also Published As

Publication number Publication date
FR2187326A1 (fr) 1974-01-18
AU468199B2 (en) 1976-01-08
US3892852A (en) 1975-07-01
GB1418208A (en) 1975-12-17
AU5677373A (en) 1974-12-12
CA1009150A (en) 1977-04-26
FR2187326B1 (fr) 1975-10-17
DE2329821A1 (de) 1974-01-03

Similar Documents

Publication Publication Date Title
ZA733811B (en) Pharmaceutical compositions containing cysteine
ZA731808B (en) Pharmaceutical compositions
IE34966L (en) Pharmaceutical composition containing substitiuted¹biguanides
ZA733812B (en) Cysteine derivatives
IL50000A (en) Pharmaceutical compositions containing carboxythioxanthene (-thioxanthone-phenoxathiine,-thianthrene or -dibenzothiophene) dioxides,certain such novel compounds and their preparation
HK41078A (en) Pharmaceutical composition
IL43837A0 (en) New aminophenyl-ethanolamines and corresponding oxazolidines,their preparation and pharmaceutical compositions containing them
ZA733406B (en) Pharmaceutical formulations
IL43766A0 (en) Pharmaceutical compositions containing bis-phenolalkane derivatives
IL43722A0 (en) Novel 2-aminomethyleneindanones and pharmaceutical compositions containing them
AU5561973A (en) Pharmaceutical composition incorporating carnitine pharmaceutical composition incorporating carnitine
MY7700009A (en) Pharmaceutical compositions containing bischromonyloxy compounds
AU475599B2 (en) Pharmaceutical compositions
GB1365030A (en) Oral compositions
PH11231A (en) Piperidinesulfonylurea derivatives and pharmaceutical compositions containing them
ZA734996B (en) Oral composition
AU5731773A (en) 2-oxo-indoline compounds and pharmaceutical compositions
JPS5452737A (en) Perfume composition
ZA731012B (en) Pharmaceutical compositions
ZA732439B (en) Pharmaceutical composition
IL41564A0 (en) Pharmaceutical compositions containing n-cyclohexyl-benzylamine derivatives
CY940A (en) Pharmaceutical formulations
ZA734331B (en) Pharmaceutical compositions
CA1006816A (fr) Compositions pharmaceutiques
AU471794B2 (en) Iodophor-steroid pharmaceutical compositions